CD36 and ovarian cancer: A body of knowledge and evidence has been collected for CD36, indicating a critical role in many entities, as CRC, gastric, cervical or ovarian cancer, impacting an array of signaling pathways, but the overall conclusion concerning the role of CD36 remains inconsistent [36].